Fengzhen Mo

663 citations
23 papers · 547 · h-index 15

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cancer Cells and Metastasis

Papers in

    • Immunotherapy and Immune Responses 10
    • Cancer Immunotherapy and Biomarkers 6
    • CAR-T cell therapy research 5

Fengzhen Mo

22 papers receiving 538 citations

Peers

Fengzhen Mo
Comparison fields: 5 of 50
  • Immunology 157
  • Oncology 166
  • Biomaterials 82
  • Radiology, Nuclear Medicine and Imaging 105
  • Drug Discovery 1
Replace Xiaoqiong Hou with:
Xiaoqiong Hou China
Zhuoran Tang China
Shihua Yin China
Siliang Duan China
Khue G. Nguyen United States
Eric F. Zhu United States
Adrienne M. Rothschilds United States
Shenxia Xie China
Xinyuan Shen China
Siena M. Mantooth United States
Fengzhen Mo relative to Xiaoqiong Hou China Xiaoqiong Hou's profile →
Citations per field
00.5×1.5×
Xiaoqiong Hou · 1×
Citations per year

Countries citing papers authored by Fengzhen Mo

Since Specialization
Citations

This map shows the geographic impact of Fengzhen Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhen Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhen Mo more than expected).

Fields of papers citing papers by Fengzhen Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengzhen Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhen Mo. The network helps show where Fengzhen Mo may publish in the future.

Co-authors

The 25 scholars most cited alongside Fengzhen Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fengzhen Mo Line = papers co-authored together Fengzhen Mo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201885
2 202164
3 201840
4 202039
5 202136
6 201733
7 201831
8 201931
9 201923
10 202322
11 201918
12 202318
13 202418
14 201917
15 201816
16 201915
17 202013
18 202113
19 20197
20 20255

About Fengzhen Mo

Fengzhen Mo is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biomaterials and Molecular Biology, having authored 23 papers that have together received 547 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Nanoparticle-Based Drug Delivery (2 papers), RNA Interference and Gene Delivery (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Immunology (157 citations), Oncology (166 citations), Biomaterials (82 citations), Radiology, Nuclear Medicine and Imaging (105 citations) and Drug Discovery (1 citation). Fengzhen Mo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoling Lü, Xiaoqiong Hou, Zhuoran Tang, Xiaomei Yang, Aiqun Liu, Siliang Duan, Shihua Yin, Zixi Hu, Xiaomei Yang and Shenxia Xie. Their work appears in journals such as Journal of Biomedical Nanotechnology, Theranostics, International Journal of Nanomedicine, Journal of Hematology & Oncology and Journal of Nanoscience and Nanotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact